|±¾ÆÚĿ¼/Table of Contents|

[1]ÕÅÀòÀò,³ÂÏþÇì,ÍõÒã.¹ÚÐIJ¡ºÏ²¢´úл×ÛºÏÕ÷»¼ÕßѪ°×ϸ°ûºÍÄòËáµÄ±ä»¯¼°ÒâÒå[J].¹ú¼ÊÐÄѪ¹Ü²¡ÔÓÖ¾,2015,06:419-421.
¡¡ZHANG Lili,CHEN Xiaoqing,WANG Yi..Variation and clinical significance of leucocytes and serum uric acid in patients with coronary heart disease complicated with metabolic syndrome[J].International Journal of Cardiovascular Disease,2015,06:419-421.
µã»÷¸´ÖÆ

¹ÚÐIJ¡ºÏ²¢´úл×ÛºÏÕ÷»¼ÕßѪ°×ϸ°ûºÍÄòËáµÄ±ä»¯¼°ÒâÒå(PDF)

¡¶¹ú¼ÊÐÄѪ¹Ü²¡ÔÓÖ¾¡·[ISSN:1006-6977/CN:61-1281/TN]

ÆÚÊý:
2015Äê06ÆÚ
Ò³Âë:
419-421
À¸Ä¿:
ÁÙ´²Ñо¿
³ö°æÈÕÆÚ:
2015-11-25

ÎÄÕÂÐÅÏ¢/Info

Title:
Variation and clinical significance of leucocytes and serum uric acid in patients with coronary heart disease complicated with metabolic syndrome
×÷Õß:
ÕÅÀòÀò³ÂÏþÇìÍõÒã
200080 ÉϺ£½»Í¨´óѧ¸½ÊôµÚÒ»ÈËÃñÒ½ÔºÐÄÄÚ¿Æ
Author(s):
ZHANG Lili CHEN Xiaoqing WANG Yi.
Department of Cardiology, Shanghai General Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 200080, China
¹Ø¼ü´Ê:
¹ÚÐIJ¡´úл×ÛºÏÕ÷GensiniÆÀ·ÖѪÄòËá°×ϸ°û
Keywords:
Coronary heart disease Metabolic syndrome Gensini score Uric acid Leucocytes
·ÖÀàºÅ:
-
DOI:
10.3969/j.issn.1673-6583.2015.06.014
ÎÄÏ×±êʶÂë:
-
ÕªÒª:
Ä¿µÄ:·ÖÎö¹ÚÐIJ¡ºÏ²¢´úл×ÛºÏÕ÷(MS)»¼ÕßѪ°×ϸ°ûºÍѪÄòËáµÄ±ä»¯¼°ÒâÒå¡£·½·¨:ÈëÑ¡275Àý¹ÚÐIJ¡»¼Õß,ÆäÖв»ºÏ²¢MSµÄ»¼Õß102Àý(·ÇMS×é),ºÏ²¢MSµÄ»¼Õß173Àý(MS×é)¡£¼ì²â»¼ÕßѪÄòËáºÍ°×ϸ°û¼ÆÊý,ÔËÓÃGensiniÆÀ·Ö·¨ÆÀ¹À¹Ú×´¶¯ÂöÏÁÕ­³Ì¶È¡£½á¹û:MS×黼ÕßѪÄòËá[(331.1±86.7)¦Ìmol/L¶Ô(357.1±84.3)¦Ìmol/L,P=0.015]¡¢°×ϸ°û¼ÆÊý[(6.4±1.8)×109/L¶Ô(7.1±
Abstract:
Objective:To investigate the variation and clinical significance of leucocytes and serum uric acid in patients with coronary heart disease(CHD)and metabolic syndrome(MS). Methods:A total of 275 patients with CHD were enrolled, including 102 patients witho

²Î¿¼ÎÄÏ×/References

[1] Arbel Y, Havakuk O, Halkin A, et al. Relation of metabolic syndrome with long-term mortality in acute and stable coronary disease[J]. Am J Cardiol, 2015, 115(3): 283-287.
[2] Ärnlöv J, Ingelsson E, Sundström J, et al. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men[J]. Circulation, 2010, 121(2): 230-236.
[3] Oda E. Serum uric acid is an independent predictor of metabolic syndrome in a Japanese health screening population[J]. Heart Vessels, 2014, 29(4): 496-503.
[4] Okura T, Higaki J, Kurata M, et al. Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis subanalysis of the Japanese Coronary Artery Disease(JCAD)study[J]. Circ J, 2009, 73(5): 885-891.
[5] Pizzi C, De Stavola BL, Meade TW. Long-term association of routine blood count(Coulter)variables on fatal coronary heart disease: 30-year results from the first prospective Northwick Park Heart Study(NPHS-I)[J]. Int J Epidemiol, 2010, 39(1): 256-265.
[6] ºÎÁ÷Ñú,ÕÔ½¨ÖÐ,ÆÝ´º½¨,µÈ.ÃâÒßϸ°ûÔÚ¶¯ÂöÖàÑùÓ²»¯ÖеÄ×÷ÓÃ[J].¹ú¼ÊÐÄѪ¹Ü²¡ÔÓÖ¾,2013,40(3):139-141.
[7] Gur M, ÿðþ‰Cahin DY, Elbasan Z, et al. Uric acid and high sensitive C-reactive protein are associated with subclinical thoracic aortic atherosclerosis[J]. J Cardiol, 2013, 61(2): 144-148.
[8] Puddu P, Puddu GM, Cravero E, et al. Relationships among hyperuricemia, endothelial dysfunction, and cardiovascular diseases: molecular mechanisms and clinical implications[J]. J Cardiol, 2012, 59(3): 235-242.
[9] Verdoia M, Barbieri L, Schaffer A, et al. Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: A single-centre cohort study[J]. Metabolism, 2014, 63(5): 640-646.
[10] ³ÂÒ»Öñ,ÕÅ¿¡·å.ƽ¾ùѪС°åÌå»ýÓëÐÄѪ¹Ü¼²²¡µÄ¹Øϵ[J].¹ú¼ÊÐÄѪ¹Ü²¡ÔÓÖ¾,2014,14(5):294-296.
[11] Kounis NG, Soufras GD, Tsigkas G, et al. White blood cell counts, leukocyte ratios, and eosinophils as inflammatory markers in patients with coronary artery disease[J]. Clin Appl Thromb Hemost, 2015,21(2):139-143.

±¸×¢/Memo

±¸×¢/Memo:
»ù½ðÏîÄ¿:¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð(81470471) ×÷Õßµ¥Î»:200080 ÉϺ£½»Í¨´óѧ¸½ÊôµÚÒ»ÈËÃñÒ½ÔºÐÄÄÚ¿Æ Í¨ÐÅ×÷Õß:Íõ Òã,Email:wangyi2004a@aliyun.com
¸üÐÂÈÕÆÚ/Last Update: 2015-12-20